In the upstream medical aesthetics device market, photoelectric-based procedures have seen a surge in consumer demand due to their advantages of high efficacy and low risk. This sector boasts strong growth potential and has attracted significant capital interest. Since 2021, among more than 30 upstream medical aesthetics companies that have secured financing, photoelectric medical aesthetics has emerged as a key sector heavily backed by investors. As a segment with deterministic high-speed growth over the next decade, the high-end photoelectric medical aesthetics equipment field presents a triple opportunity for regulatory compliance upgrades, import substitution with domestically produced alternatives, and source innovation, coinciding with a rare market window.
Against this backdrop, VCBeat VB100, in partnership with Fumilei, is hosting the Forum on Innovative Development of Photoelectric Medical Aesthetics and releasing the White Paper on Energy-Based Devices in Medical Aesthetics. Focusing on the high-demand sector of high-end medical devices—photoelectric medical aesthetic equipment—the forum will bring together top industry experts and leaders. Leveraging their keen insights into the industry and continuous innovative practices, they will jointly create a premier platform for industrial exchange.


2023 Future Healthcare Top 100 Conference, organized by VB100, VCBeat, and Eggshell Research Institute, with strategic partnership support from Shanghai Zhangjiang Group, will be grandly held at the Shanghai Zhangjiang Science Hall from May 5-7, 2023. Led by Academician Robert Langer and IEEE scientists, nearly 500 industry leaders will gather for 3 main forums and 31 hot-topic forums!